The LQB-223 Compound Modulates Antiapoptotic Proteins and Impairs Breast Cancer Cell Growth and Migration

Drug resistance represents a major issue in treating breast cancer, despite the identification of novel therapeutic strategies, biomarkers, and subgroups. We have previously identified the LQB-223, 11a-N-Tosyl-5-deoxi-pterocarpan, as a promising compound in sensitizing doxorubicin-resistant breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lemos, Lauana Greicy Tonon, Longo, Gabriel Mello da Cunha, Mendonça, Bruna dos Santos, Robaina, Marcela Cristina, Brum, Mariana Concentino Menezes, Cirilo, Caíque de Assis, Gimba, Etel Rodrigues Pereira, Costa, Paulo Roberto Ribeiro, Buarque, Camilla Djenne, Nestal de Moraes, Gabriela, Maia, Raquel Ciuvalschi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834317/
https://www.ncbi.nlm.nih.gov/pubmed/31614718
http://dx.doi.org/10.3390/ijms20205063

Ejemplares similares

Ejemplares similares